These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 564775)

  • 1. Effect of muscimol on single unit activity of substantia nigra dopamine neurons.
    Walters JR; Lakoski JM
    Eur J Pharmacol; 1978 Feb; 47(4):469-71. PubMed ID: 564775
    [No Abstract]   [Full Text] [Related]  

  • 2. The action of muscimol on neurones of the substantia nigra of the rat.
    Olpe HR; Koella WP
    Experientia; 1978 Feb; 34(2):235. PubMed ID: 564284
    [No Abstract]   [Full Text] [Related]  

  • 3. Response of dopamine neurons in substantia nigra to muscimol.
    MacNeil D; Gower M; Szymanska I
    Brain Res; 1978 Oct; 154(2):401-3. PubMed ID: 688000
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons.
    Waszczak BL; Eng N; Walters JR
    Brain Res; 1980 Apr; 188(1):185-97. PubMed ID: 7370752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single unit responses of substantia nigra and globus pallidus neurons to GABA agonist and antagonist drugs.
    Waszczak BL; Bergstrom DA; Walters JR
    Adv Biochem Psychopharmacol; 1981; 30():79-94. PubMed ID: 7331938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotational behaviour after unilateral intranigral injection of muscimol in rats.
    Oberlander C; Dumont C; Boissier JR
    Eur J Pharmacol; 1977 Jun; 43(4):389-90. PubMed ID: 560304
    [No Abstract]   [Full Text] [Related]  

  • 7. GABA-mediated control of rat neostriatal tyrosine hydroxylase revealed by intranigral muscimol.
    Gale KN; Guidotti A
    Nature; 1976 Oct; 263(5579):691-3. PubMed ID: 10528
    [No Abstract]   [Full Text] [Related]  

  • 8. Nigral-derived muscimol circling--ipsiversive, contraversive or controversial?
    Starr MS; Kilpatrick IC
    Nature; 1981 Apr; 290(5807):610. PubMed ID: 6261148
    [No Abstract]   [Full Text] [Related]  

  • 9. GABA agonists and potential antagonists related to muscimol.
    Arnt J; Krogsgaard-Larsen P
    Brain Res; 1979 Nov; 177(2):395-400. PubMed ID: 227538
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol.
    Xu D; Karain B; Brantley E; Shi WX
    J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological evidence for a dopaminergic action of LSD: depression of unit activity in the substantia nigra of the rat.
    Christoph GR; Kuhn DM; Jacobs BL
    Life Sci; 1977 Dec; 21(11):1585-96. PubMed ID: 202830
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscimol antagonizes the ergometrine-induced locomotor activity in nucleus accumbens: evidence for a GABA--dopaminergic interaction.
    Scheel-Krüger J; Cools AR; Honig W
    Eur J Pharmacol; 1977 Apr; 42(3):311-3. PubMed ID: 852502
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of clonidine on dopaminergic neuron activity in the substantia nigra: possible indirect mediation by noradrenergic regulation of the serotonergic raphé system.
    Bunney BS; DeRiemer S
    Adv Neurol; 1982; 35():99-104. PubMed ID: 7148583
    [No Abstract]   [Full Text] [Related]  

  • 14. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesion of substantia nigra pars compacta by the GluR5 agonist ATPA.
    Vivó M; Camón L; de Vera N; Martínez E
    Brain Res; 2002 Nov; 955(1-2):104-14. PubMed ID: 12419526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
    Lee CR; Abercrombie ED; Tepper JM
    Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
    Julou L; Scatton B; Glowinski J
    Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
    [No Abstract]   [Full Text] [Related]  

  • 18. Oscillation of interspike interval length in substantia nigra dopamine neurons: effects of nicotine and the dopaminergic D2 agonist LY 163502 on electrophysiological activity.
    Carlson JH; Foote SL
    Synapse; 1992 Jul; 11(3):229-48. PubMed ID: 1636152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis toxin lesions of the rat substantia nigra block the inhibitory effects of the gamma-hydroxybutyrate agent, S(-)HA-966 without affecting the basal firing properties of dopamine neurons.
    Shepard PD; Connelly ST
    Neuropsychopharmacology; 1999 Nov; 21(5):650-61. PubMed ID: 10516961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro.
    Keegan KD; Woodruff GN; Pinnock RD
    Br J Pharmacol; 1992 Jan; 105(1):3-5. PubMed ID: 1375857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.